Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹102.26Admitted-Finance | ₹102.26 | L1 | Admitted-Finance |
| 2 | L2₹3,006.80+₹2,904.54 (2840.3%)Admitted-Finance | ₹3,006.80+₹2,904.54 (2840.3%) | L2 | Admitted-Finance |
| 3 | L3₹5,992+₹5,889.74 (5759.6%)Admitted-Finance DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R 282 ITC AREA OF MIDC THANE BELAPUR ROAD RABALE NAVI MUMBAI 400701 | NAVI MUMBAI | THANE | MAHARASHTRA | 400701 | ₹5,992+₹5,889.74 (5759.6%) | L3 | Admitted-Finance |
| 4 | L4₹6,907.04+₹6,804.78 (6654.4%)Admitted-Finance | ₹6,907.04+₹6,804.78 (6654.4%) | L4 | Admitted-Finance |
| 5 | L5₹8,218.56+₹8,116.30 (7936.9%)Admitted-Finance CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 | AHMADABAD | GUJARAT | 380054 | ₹8,218.56+₹8,116.30 (7936.9%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | AstraZeneca Pharma India Limited L6 | Intas Pharmaceuticals limited L5 | Reliance Life Sciences Pvt. Ltd. L3 | M/s. Hetero Healthcare Limited L4 | Pfizer Limited L2 | ENCUBE ETHICALS PRIVATE LIMITED L1 |
|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj. Goserelin Acetate 3.6mg PFS | 1 | Per PFS | 3,500 ₹3,675 Lowest | - | - | - | - | - |
| 2.00 | Inj. Goserelin Acetate10.8mg PFS | 1 | Per PFS | 16,500 ₹17,325 Lowest | - | - | - | - | - |
| 3.00 | Tab. Olaparib 150mg film coated | 1 | Per Tablet | 3,340.68 ₹3,741.56 Lowest | - | - | - | - | - |
| 4.00 | Tab. Olaparib100mg film coated | 1 | Per Tablet | 3,307.62 ₹3,704.53 Lowest | - | - | - | - | - |
| 5.00 | Tab. Osimertinib 80mg | 1 | Per Tablet | 9,262.7 ₹10,374.22 Lowest | - | - | - | - | - |
| 6.00 | Inj. Durvalumab 120mg/2.4ml | 1 | Per 2.4ml vial | 27,785.1 ₹31,119.31 Lowest | - | - | - | - | - |
| 7.00 | Inj. Durvalumab 500mg/10ml | 1 | Per 10ml vial | 1,15,772.27 ₹1,29,664.94 Lowest | - | - | - | - | - |
| 8.00 | Tab. Methadone 10mg | 1 | Per tab | - | - | - | - | - | - |
| 9.00 | Tab. Naltrexone 50mg | 1 | Per Tablet | - | - | - | - | - | - |
| 10.00 | Tab. Disulfiram 250mg | 1 | Per Tablet | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
28 Oct 2022, 4:00 pmClosed
Managing Director -JKMSCL
OFFICE OF JKMSCL
Allopathic Drugs 2022 (Addendum Items )
2022_HME_184847_2
JKMSCL/Allopathic Drugs 2022/541 dt20.08.2022
Open Tender
Medicines
Item Wise
730 days
Jammu / Srinager
Please refer Tender documents.
2 documents required · 2 mandatory
₹10,000
As per NIT through NEFT
₹1 L
Yes
30 Jan 2023
6 Oct 2022
29 Oct 2022
6 Oct 2022
28 Oct 2022
6 Oct 2022
Inj. Goserelin Acetate 3.6mg PFS
Inj. Goserelin Acetate10.8mg PFS
Tab. Olaparib 150mg film coated
Tab. Olaparib100mg film coated
Tab. Osimertinib 80mg
Inj. Durvalumab 120mg/2.4ml
Inj. Durvalumab 500mg/10ml
Tab. Methadone 10mg
Tab. Naltrexone 50mg
Tab. Disulfiram 250mg
Inj. Rituximab 500mg/50ml vial
Inj. Filgrastim 300mcg, 1ml PFS
Cream Framycetin 1% w/v , 100gram tube
Inj. Pneumococcal Polysacheride Conjugate Vaccine 13- valent,0.5ml PFS
Inj. Iopromide injection 77% w/v, 370 mg I/mL,100ml bottle
Inj. Gadobutrol 1.0mmol/ml, 5ml vial
Pfizer Limited
Reliance Life Sciences Pvt. Ltd.
M/s. Hetero Healthcare Limited
Intas Pharmaceuticals limited
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited
Item code 1679
Item code 1680
Item code 1681
Item code 1682
Item code 1683
Item code 1684
Intas Pharmaceuticals limited
Pfizer Limited
Reliance Life Sciences Pvt. Ltd.
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .